About this trial
Heart Failure and valvular heart disease are disproportionate problems in rural and remote Australia (RRA). Echocardiography is the best imaging investigation, and essential for management, but access to this essential test shows huge geographic variations, primarily because of dependence on expert acquisition. This trial seeks to demonstrate the effectiveness of artificial intelligence-based echocardiography for triage and management of patients with known or suspected heart disease in RRA.
Eligibility criteria
Qualifiers
Age >45 years
eligible for Medicare
exercise intolerance or cardiovascular (CV) risk factors
Disqualifiers
Known HF or HVD
situations where cardio-protection is already indicated (eg. known CAD)
comorbid conditions with life expectancy <2 years
inability to provide written informed consent
Trial design
Treatments tested in this trial
- AI-guided echo
- Standard echo
Treatment groups
Sponsors and collaborators
Baker Heart and Diabetes Institute
Lead sponsor
Alice Springs Hospital
Collaborator
Princess Alexandra Hospital, Brisbane, Australia
Collaborator
Royal Perth Hospital
Collaborator
Ochre Health
Collaborator
Walgett Aboriginal Medical Services
Collaborator
Merriden Health Service
Collaborator
Royal Hobart Hospital
Collaborator
Quairading Medical Practice
Collaborator